| Bioactivity | CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain). CEF19, Epstein-Barr Virus latent NA-3A (458-466) can significantly affect cytotoxic T-lymphocyte (CTL) recognition[1]. |
| Name | CEF19, Epstein-Barr Virus latent NA-3A (458-466) |
| CAS | 157876-41-0 |
| Sequence | Tyr-Pro-Leu-His-Glu-Gln-His-Gly-Met |
| Shortening | YPLHEQHGM |
| Formula | C49H70N14O14S |
| Molar Mass | 1111.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee SP, et al. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur J Immunol. 1995 Jan;25(1):102-10. |
CEF19, Epstein-Barr Virus latent NA-3A (458-466)
CAS: 157876-41-0 F: C49H70N14O14S W: 1111.23
CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.